ImmuCell
(NASDAQ) ICCC
ImmuCell Financials at a Glance
Market Cap
$89.25M
Revenue (TTM)
$29.93M
Net Income (TTM)
-$545.40K
EPS (TTM)
-$0.06
P/E Ratio
-163.87
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Price
$9.71
Volume
38,840
Open
$9.97
Price
$9.71
Volume
38,840
Open
$9.97
Previous Close
$9.79
Daily Range
$9.51 - $10.10
52-Week Range
$4.52 - $10.75
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.21 (Low)
Price
$9.71
Volume
38,840
Open
$9.97
Previous Close
$9.79
Daily Range
$9.51 - $10.10
52-Week Range
$4.52 - $10.75
Estimated Earnings Date
Aug 13, 2026
ICCC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout ImmuCell
Industry
Biotechnology
Sector
Health CareEmployees
73
CEO
Olivier te Boekhorst
Website
www.immucell.comHeadquarters
Portland, ME 04103, US
ICCC Financials
Key Financial Metrics (TTM)
Gross Margin
42.59%
Operating Margin
8.35%
Net Income Margin
-1.82%
Return on Equity
-1.88%
Return on Capital
4.10%
Return on Assets
-1.24%
Earnings Yield
-0.61%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$89.25M
Shares Outstanding
9.05M
Volume
38.84K
Avg. Volume
26.92K
Financials (TTM)
Gross Profit
$12.75M
Operating Income
$2.50M
EBITDA
$2.39M
Operating Cash Flow
$4.47M
Capital Expenditure
-$1.10M
Free Cash Flow
$3.38M
Cash & ST Invst.
$6.81M
Total Debt
$12.78M
ImmuCell Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.36M
+28.4%
Gross Profit
$4.66M
+38.9%
Gross Margin
44.97%
N/A
Market Cap
$89.25M
N/A
Market Cap/Employee
$1.29M
N/A
Employees
69
N/A
Net Income
$1.94M
+34.2%
EBITDA
$2.58M
+15.2%
Quarterly Fundamentals
Total Cash
$6.81M
+48.1%
Total Debt
$12.78M
-12.8%
Accounts Receivable
$2.69M
-20.8%
Inventory
$8.67M
+17.9%
Long Term Debt
$11.06M
-13.3%
Short Term Debt
$1.72M
-9.5%
Return on Assets
-1.24%
N/A
Return on Invested Capital
6.22%
N/A
Free Cash Flow
$3.40M
+172.8%
Operating Cash Flow
$3.57M
+127.0%